The radiosensitivity of HNSCC cells was previously shown to improve upon impairing of HIF-1α expression [22] and the mTOR inhibitor CCI-779 was shown to potentiate the efficacy of radiotherapy in HNSCC xenograft models [23]. Here, MTOR is linked to head and neck squamous cell carcinoma.